DCF Advisers, LLC Buys Impel NeuroPharma Inc, argenx SE, Apple Inc, Sells Alphabet Inc, , Oracle Corp

• New Purchases: IMPL, MRVL, AZN, LIT, TBT, WBA, ET, OCX,
• Added Positions: ARGX, XNCR, AAPL, ALT, EQ, VIR, BABA, F, INCY, MU, AERI, SLV, REGN, BIIB, ITCI, VIAC, LCTX, AIRT, OVID,
• Reduced Positions: GOOG, ORCL, GLD, AMD, TPB, MS, GM, BMY, GDXJ, GDX, MTNB, AOD, PRTA, BIF, AMRN, QTNT, BOX,
• Sold Out: KIN, ALXN, JNJ, IBM, KSS, KWEB, NLOK, GMAB, AYX, TSM, SGMO, OBSV,

For the details of DCF Advisers, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/dcf+advisers%2C+llc/current-portfolio/portfolio

1. S&P 500 ETF TRUST ETF (SPY) - 67,500 shares, 12.79% of the total portfolio.
2. Intra-Cellular Therapies Inc (ITCI) - 379,000 shares, 6.24% of the total portfolio. Shares added by 1.07%
3. Micron Technology Inc (MU) - 177,500 shares, 5.56% of the total portfolio. Shares added by 4.41%
4. Alphabet Inc (GOOG) - 4,350 shares, 5.12% of the total portfolio. Shares reduced by 33.08%
5. Regeneron Pharmaceuticals Inc (REGN) - 16,000 shares, 4.27% of the total portfolio. Shares added by 3.23%

DCF Advisers, LLC initiated holding in Impel NeuroPharma Inc. The purchase prices were between $8.38 and $26.13, with an estimated average price of $14.5. The stock is now traded at around $10.960000. The impact to a portfolio due to this purchase was 0.81%. The holding were 150,000 shares as of 2021-09-30.

DCF Advisers, LLC initiated holding in Marvell Technology Inc. The purchase prices were between $53.97 and $63.61, with an estimated average price of $59.93. The stock is now traded at around $72.920000. The impact to a portfolio due to this purchase was 0.47%. The holding were 17,500 shares as of 2021-09-30.

DCF Advisers, LLC initiated holding in AstraZeneca PLC. The purchase prices were between $55.56 and $60.79, with an estimated average price of $58.25. The stock is now traded at around $59.780000. The impact to a portfolio due to this purchase was 0.34%. The holding were 12,745 shares as of 2021-09-30.

DCF Advisers, LLC initiated holding in Global X Lithium & Battery Tech ETF. The purchase prices were between $72.05 and $87.02, with an estimated average price of $81.98. The stock is now traded at around $93.260000. The impact to a portfolio due to this purchase was 0.34%. The holding were 9,500 shares as of 2021-09-30.

DCF Advisers, LLC initiated holding in PowerShares UltraShort Lehman 20+ Year Treasury Pr. The purchase prices were between $16.66 and $18.81, with an estimated average price of $17.53. The stock is now traded at around $17.810000. The impact to a portfolio due to this purchase was 0.24%. The holding were 30,000 shares as of 2021-09-30.

DCF Advisers, LLC initiated holding in Walgreens Boots Alliance Inc. The purchase prices were between $45.58 and $51.78, with an estimated average price of $48.28. The stock is now traded at around $49.220000. The impact to a portfolio due to this purchase was 0.1%. The holding were 5,000 shares as of 2021-09-30.

DCF Advisers, LLC added to a holding in argenx SE by 25.00%. The purchase prices were between $295 and $350.58, with an estimated average price of $317.39. The stock is now traded at around $301.200000. The impact to a portfolio due to this purchase was 0.67%. The holding were 25,000 shares as of 2021-09-30.

DCF Advisers, LLC added to a holding in Apple Inc by 150.00%. The purchase prices were between $137.27 and $156.69, with an estimated average price of $147.22. The stock is now traded at around $150.000000. The impact to a portfolio due to this purchase was 0.47%. The holding were 12,500 shares as of 2021-09-30.

DCF Advisers, LLC added to a holding in Altimmune Inc by 64.12%. The purchase prices were between $8.43 and $16.81, with an estimated average price of $12.18. The stock is now traded at around $11.160000. The impact to a portfolio due to this purchase was 0.46%. The holding were 239,200 shares as of 2021-09-30.

DCF Advisers, LLC added to a holding in Equillium Inc by 139.45%. The purchase prices were between $4.84 and $6.91, with an estimated average price of $5.9. The stock is now traded at around $5.610000. The impact to a portfolio due to this purchase was 0.33%. The holding were 185,666 shares as of 2021-09-30.

DCF Advisers, LLC added to a holding in Vir Biotechnology Inc by 131.96%. The purchase prices were between $34.9 and $54.54, with an estimated average price of $43.35. The stock is now traded at around $32.890000. The impact to a portfolio due to this purchase was 0.31%. The holding were 28,000 shares as of 2021-09-30.

DCF Advisers, LLC added to a holding in Alibaba Group Holding Ltd by 45.00%. The purchase prices were between $145.08 and $221.87, with an estimated average price of $182.3. The stock is now traded at around $166.540000. The impact to a portfolio due to this purchase was 0.29%. The holding were 14,500 shares as of 2021-09-30.

DCF Advisers, LLC sold out a holding in . The sale prices were between $9.08 and $9.25, with an estimated average price of $9.19.

DCF Advisers, LLC sold out a holding in . The sale prices were between $179.45 and $186.61, with an estimated average price of $183.84.

DCF Advisers, LLC sold out a holding in Johnson & Johnson. The sale prices were between $161.5 and $179.47, with an estimated average price of $170.65.

DCF Advisers, LLC sold out a holding in International Business Machines Corp. The sale prices were between $127.01 and $140.26, with an estimated average price of $133.56.

DCF Advisers, LLC sold out a holding in Kohl's Corp. The sale prices were between $47.09 and $60.18, with an estimated average price of $53.5.

DCF Advisers, LLC sold out a holding in KraneShares CSI China Internet ETF. The sale prices were between $43.96 and $68.27, with an estimated average price of $52.47.